Seoul National University Hospital

Public research footprint of Seoul National University Hospital, compiled from the ClinicalTrials.gov public registry.

3,603

Registered studies

961

Active

520

Recruiting now

1,807

Completed

300

Stopped or withdrawn

Most-studied conditions

Multiple Myeloma · Resectable Pancreatic Ductal Adenocarcinoma (PDAC) · B-cell Non-Hodgkin Lymphoma (B-NHL) · Non-Muscle Invasive Bladder Neoplasms

Recently updated registry entries

NCT07438496 — A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus (Recruiting)
NCT05488314 — A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic… (Active Not Recruiting)
NCT06741969 — Nipocalimab in Moderate to Severe Sjogren's Disease (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Seoul National University Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.